Forte Biosciences earnings were -$35.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest FBRX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$7.2M, down 14.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FBRX reported annual earnings of -$35.5M, with 12.7% growth.
What were Forte Biosciences's earnings last quarter?
On FBRX's earnings call on Invalid Date, Forte Biosciences (NASDAQ: FBRX) reported Q4 2024 earnings per share (EPS) of $3.18, up 434.74% year over year. Total FBRX earnings for the quarter were -$7.16 million. In the same quarter last year, Forte Biosciences's earnings per share (EPS) was -$0.95.
As of the last Forte Biosciences earnings report, Forte Biosciences is currently losing money. Forte Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$35.48 million, a 12.71% increase year over year.
What was FBRX's earnings growth in the past year?
As of Forte Biosciences's earnings date in Invalid Date, Forte Biosciences's earnings has grown year over year. FBRX earnings in the past year totalled -$35.48 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.